SpringWorks secures FDA approval of Ogsiveo to treat desmoid tumours
The FDA approval is based on positive data from the Phase 3 DeFi trial, in which Ogsiveo significantly…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Nov 23
The FDA approval is based on positive data from the Phase 3 DeFi trial, in which Ogsiveo significantly…
28 Nov 23
ARCT-032 has been designed to use the firm’s LUNAR lipid-mediated aerosolised platform to provide CFTR messenger RNA to…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
28 Nov 23
In the trial, Dupixent reduced moderate or severe acute COPD exacerbations by 34% over 52 weeks and led…
28 Nov 23
The drug achieved the primary endpoint of progression-free survival and extended the time to disease progression or death…
28 Nov 23
Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…
28 Nov 23
The construction of the two new buildings has represented an investment of 22 million euros
28 Nov 23
DxVx announces today that it will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford…
28 Nov 23
deepc, a leading MedTech company, aligns strategically with MONAI, the Medical Open Network for Artificial Intelligence. A community-driven…
28 Nov 23
Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities
28 Nov 23
New clinical data from Octapharma's haematology portfolio will be presented during the scientific program at the 65th American…